Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2006
03/29/2006EP1007554B1 Oil bodies and associated proteins as affinity matrices
03/29/2006EP0965646B1 Probe for detecting and identifying helicobacter pylori
03/29/2006EP0759465B1 Gene imparting flocculability to yeast and gene product
03/29/2006CN1753993A Detection of small nucleic acids
03/29/2006CN1753954A Monofunctionalized perylenetetracarboxylic acid bisimides
03/29/2006CN1753911A Chimeric and humanized antibodies to alpha5beta1 integrin that modulate angiogenesis
03/29/2006CN1753904A Bmp-2 estrogen responsive element and methods of using the same
03/29/2006CN1753903A Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
03/29/2006CN1753902A Pyrroles substituted by oligonucleotides
03/29/2006CN1752094A Preparation method of DNA pretreatment buffer liquid, thallus DNA and nucleic acid DNA
03/29/2006CN1247775C Attenuated cattle viral diarrhoea virus
03/29/2006CN1247612C 0sGLR1 gene of paddy and application
03/29/2006CN1247609C Carcinoma related gene and protein coded thereby
03/29/2006CN1247608C Gene therapeutic drug hdm2-siRNA for breast cancer
03/28/2006US7019131 Influence on reactivity of the structural effects of different monosaccharide cores and different protecting groups on each glycoside donor is characterized and quantified
03/28/2006US7019129 at least three radicals selected from substituted or unsubstituted aryl, heteroaryl and combinations, wherein at least two of the residues are covalently linked via an exocyclic diazo bond, and a reactive functional group providing a locus for conjugation of the quencher to a carrier
03/28/2006US7019128 For use as fluorescently labelled chain-terminating dideoxynucleotides and chain-extending primers during polymerase chain reactions
03/28/2006US7019127 Coupling of H-phosphonate with a nucleoside alcohol to form the diester; oxidation with sulfur transfer agent to form a phosphorothioate triester
03/28/2006US7019123 Human bikunin
03/28/2006US7019122 Nucleic acid sequence comprises a series of genes in the order gag (group antigen), pol (polyprotein) where the pol sequence comprises an aspartic protease, an integrase and a reverse transcriptase/RNAseH.
03/28/2006US7019116 PRO 1387 polypeptides
03/28/2006US7018985 Composition and method for inhibiting platelet aggregation
03/28/2006US7018984 Methods and compositions for controlling translation of HCV proteins
03/28/2006US7018846 Display of receptors and analysis of binding interactions and drug libraries
03/28/2006US7018837 Nucleic acids encoding secreted polypeptides that stimulate release of proteoglycans from cartilage
03/28/2006US7018832 Transport proteins for use in the treatment and diagnosis of stroke, pain, neuropathic pain and traumatic brain injury
03/28/2006US7018827 DNA sequences, complementary DNA, genetic vector and host cells for yeast, used for detection and diagnosis of infection; immunology
03/28/2006US7018823 Fructosyl peptide oxidase
03/28/2006US7018816 Real-time polymerase chain reaction-based genotyping assay for single nucleotide polymorphism
03/28/2006US7018811 Nucleic acids encoding PRO189 polypeptides
03/28/2006US7018810 Chordin-like molecules and uses thereof
03/28/2006US7018798 Solid phase thermoplastic or thermosetting resin substrate having a DNA or RNA embedded therein for hybridization assays and immunoassays to detect antinucleic acid antibody
03/28/2006US7018795 Probe for use in the detection of preferential nucleotide sequences
03/28/2006US7018794 Methods for monitoring multiple gene expression
03/28/2006US7018791 chaperone proteins; biochemical immobilization; competitive binding; drug screening
03/28/2006US7018639 polypeptide and optionally carrier and/or adjuvants having haemolysin activity used for inoculation against gramnegative bacteria; immunology
03/28/2006US7018634 Surface proteins of Leptospira
03/28/2006US7018631 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
03/28/2006US7018431 Useful as fluorescent labels of nucleosides, nucleotides, polynucleotides, and polypeptides.
03/23/2006WO2006032041A2 Compositions and methods for inhibiting expression of anti-apoptotic genes
03/23/2006WO2006031928A2 Arf-bp1 as mediator of p53-dependent and independent tumor suppression and uses thereof
03/23/2006WO2006031327A2 Cloning and expression of recombinant adhesive protein mefp-2 of the blue mussel, mytilus edulis
03/23/2006WO2006031291A2 A novel class of therapeutic protein based molecules
03/23/2006WO2006031267A2 Rna interference suppression of neurodegenerative diseases and methods of use thereof
03/23/2006WO2006030906A1 Nucleoside analogues or salts thereof
03/23/2006WO2006029459A1 Antibodies specific for hepatocellular carcinoma and other carcinomas and uses thereof
03/23/2006WO2005107396A3 Novel compositions and methods in cancer
03/23/2006WO2005059111A3 DELIVERY OF DNA OR RNA VIA GAP JUNCTIONS FROM HOST CELLS TO TARGET CELLS AND A CELL-BASED DELIVERY SYSTEM FOR ANTISENSE OR SiRNA
03/23/2006WO2005049794A3 Methods of characterizing infectious bursal disease virus
03/23/2006WO2005047459A3 Sars nucleic acids, proteins, antibodies, and uses thereof
03/23/2006WO2005046585A3 Vps35-based assays and methods for treating alzheimer’s disease
03/23/2006WO2005042743A3 Humanization of antibodies
03/23/2006WO2005035549A3 Amiphiphylic peptide-pna conjugates for the delivery of pna through the blood brain barrier
03/23/2006WO2005033125A3 Mammalian t1r3 sweet taste receptors
03/23/2006WO2005018431A3 Compositions and methods for detecting and treating neurological conditions
03/23/2006WO2005013886A3 Methods for treating and preventing apoptosis-related diseases using rna interfering agents
03/23/2006WO2005007623A8 Inhibition of syk kinase expression
03/23/2006WO2004104180A3 Genes encoding carotenoid biosynthetic enzymes
03/23/2006WO2003083085A3 Transporters and ion channels
03/23/2006US20060064773 Cell cycle polynucleotides and polypeptides and methods of use
03/23/2006US20060064765 Obesity gene
03/23/2006US20060064764 Increasing gamete production with a gene switch
03/23/2006US20060063925 solid phase; comprising a solid support having a tag oligonucleotide covalently bound to the surface of the solid support; immobilization; re-usable anchoring system for nucleic acid molecules; employed in high throughput and/or automated systems
03/23/2006US20060063924 Leukocyte regulatory factors 1 and 2
03/23/2006US20060063923 4-1BB peptides and methods for use
03/23/2006US20060063922 Epidermal differentiation factor
03/23/2006US20060063734 4,7-dichlorofluorescein dyes as molecular probes
03/23/2006US20060063731 In vivo inhibition of hepatitis B virus
03/23/2006US20060063716 Intermedin and its uses
03/23/2006US20060063709 Nuclear factors associated with transcriptional regulation
03/23/2006US20060063249 Human cathepsin
03/23/2006US20060063248 Butyrylcholinesterase variants and methods of use
03/23/2006US20060063247 Increased thermostability, photostability, and water solubility
03/23/2006US20060063245 Novel human enzymes and polynucleotides encoding the same
03/23/2006US20060063243 Cloning and expression of microbial phytase
03/23/2006US20060063236 Interleukin-4 (IL-4) mutein receptor antagonist operatively linked to an interleukin-9 (IL-9) mutein receptor antagonist; can specifically disrupt the formation of an IL-4 receptor, an IL-9 receptor, an interleukin-13 (IL-13) receptor; useful in treatment of asthma and other pulmonary disorders
03/23/2006US20060063235 DNA encoding the human serine protease C-E
03/23/2006US20060063234 Efficient production of IgM in recombinant mammalian cells
03/23/2006US20060063230 Sulfatases and methods of use thereof
03/23/2006US20060063229 mmFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof
03/23/2006US20060063228 Antibodies against human interleukin-13 and uses therefor
03/23/2006US20060063215 Human GAK-related gene variants associated with lung cancer
03/23/2006US20060063203 Vascular endothelial cell growth factor variants and uses thereof
03/23/2006US20060063200 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/23/2006US20060063194 Methods and probes for the detection of cancer
03/23/2006US20060063189 Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated DNA analysis
03/23/2006US20060063186 Multi-chromophoric quencher constructs for use in high sensitivity energy transfer probes
03/23/2006US20060063180 Method of nucleic acid isolation
03/23/2006US20060063179 MIFL- a new partner gene of MLL and methods of use thereof
03/23/2006US20060063173 Charge switch nucleotides
03/23/2006US20060063172 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample
03/23/2006US20060063167 DNA and proteins or peptides specific of the Neisseria meningitidis species bacteria, method for obtaining them and their biological applications
03/23/2006US20060063166 Nucleic acids of the human ABCC12 gene, vectors containing such nucleic acids and uses thereof
03/23/2006US20060063161 Detecting RNAi using SELDI mass spectrometry
03/23/2006US20060063156 Outcome prediction and risk classification in childhood leukemia
03/23/2006US20060063152 Novel gene and protein encoded by the gene
03/23/2006US20060063149 Compositions and methods for detecting pathogen infection
03/23/2006US20060062805 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
03/23/2006US20060062804 High sensitivity and specificity of the serologic detection; rapid, simple, low cost test for commercially available, large scale screening of SARS patients
03/23/2006US20060062803 a nucleic acid fhaving a first nucleotide sequence encoding nonstructural proteins from attenuated dengue-2 virus vaccine strain PDK-53, and a second nucleotide sequence encoding a structural protein from a second flavivirus; amino acid mutations in the nontstructural proteins; vaccines